Neuropharm
Quick facts
Marketed products
- Fluoxetine (prozac) · Psychiatry / Neurology
Fluoxetine selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: